News

Discussion in the Barouch Research Lab

'Elite neutralizing' antibody demonstrates long-term viral suppression in persons living with HIV in phase 1 trial

BIDMC physicians-scientists led a phase 1 clinical trial finding that antibody PGT121 demonstrated antiviral activity in adults living with HIV. Read more.

Oct. 14, 2021